Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Conba Pharma Plans $148 Million Private Placement

publication date: May 14, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Zhejiang Conba Pharma will raise as much as 925 million RMB ($148 million) via a private placement of 120 million shares at 7.71 RMB each. The funds will be used to boost working capital, according to a company filing. Insiders will purchase the entirety, or at least the majority, of the offering. The new funds add about 15% to Conba's capital base, as the company currently has a market capitalization of $1 billion. More details....

Stock Symbol: (SHA: 600572)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners